Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geert-Jan Creemers

Showing results (21-30 of 95) with videos related to

Pageof 10
Sort By:
Endoscopy International Open|September 14, 2018
Salvage endoscopic resection in patients with esophageal adenocarcinoma after chemoradiotherapyIrma C Noordzij, Wouter L Curvers, Clément J Huysentruyt, et al.
Clinical Colorectal Cancer|January 15, 2016
Bevacizumab in Addition to Palliative Chemotherapy for Patients With Peritoneal Carcinomatosis of Colorectal Origin: A Nationwide Population-Based StudyLieke G E M Razenberg, Yvette R B M van Gestel, Valery E P P Lemmens, et al.
World Journal of Gastrointestinal Surgery|November 11, 2016
Phase II study of docetaxel, cisplatin and capecitabine as preoperative chemotherapy in resectable gastric cancerAnneriet E Dassen, Nienke Bernards, Valery E P P Lemmens, et al.
Clinical Colorectal Cancer|March 22, 2025
Treatment Adherence to Adjuvant Chemotherapy According to the New Standard 3-month CAPOX Regimen in High-risk Stage II and Stage III Colon Cancer: A Population-based Evaluation in The NetherlandsKim van den Berg, Felice N van Erning, Jacobus Wa Burger, et al.
Journal of Geriatric Oncology|February 24, 2015
Deciding on adjuvant chemotherapy for elderly patients with stage III colon cancer: a qualitative insight into the perspectives of surgeons and medical oncologistsFelice N van Erning, Maryska L G Janssen-Heijnen, Geert-Jan Creemers, et al.
The Oncologist|August 12, 2025
Emerging treatment modalities for gastric cancer with peritoneal metastases: A systematic reviewMarion Wilhelmina Tops-Welten, Laskarina Jaklien Konstantina Galanos, Geert-Jan Creemers, et al.
Journal of Clinical Gastroenterology|March 31, 2012
The effect of socioeconomic status on staging and treatment decisions in esophageal cancerPauline Bus, Mieke J Aarts, Valery E P P Lemmens, et al.
Annals of Surgical Oncology|February 5, 2016
Local Recurrence in the Lateral Lymph Node Compartment: Improved Outcomes with Induction Chemotherapy Combined with Multimodality TreatmentMiranda Kusters, Sietske J Bosman, Desley M G I Van Zoggel, et al.
Cancer Medicine|September 28, 2016
The use of adjuvant chemotherapy for pancreatic cancer varies widely between hospitals: a nationwide population-based analysisMaikel J Bakens, Lydia G van der Geest, Magreet van Putten, et al.
American Journal of Clinical Oncology|February 9, 2012
Addition of biological therapies to palliative chemotherapy prolongs survival in patients with peritoneal carcinomatosis of colorectal originYvonne L B Klaver, Bart J M Leenders, Geert-Jan Creemers, et al.
Pageof 10

Showing results (21-30 of 95) with videos related to

Sort By:
Pageof 10
Endoscopy International Open|September 14, 2018
Salvage endoscopic resection in patients with esophageal adenocarcinoma after chemoradiotherapyIrma C Noordzij, Wouter L Curvers, Clément J Huysentruyt, et al.
Clinical Colorectal Cancer|January 15, 2016
Bevacizumab in Addition to Palliative Chemotherapy for Patients With Peritoneal Carcinomatosis of Colorectal Origin: A Nationwide Population-Based StudyLieke G E M Razenberg, Yvette R B M van Gestel, Valery E P P Lemmens, et al.
World Journal of Gastrointestinal Surgery|November 11, 2016
Phase II study of docetaxel, cisplatin and capecitabine as preoperative chemotherapy in resectable gastric cancerAnneriet E Dassen, Nienke Bernards, Valery E P P Lemmens, et al.
Clinical Colorectal Cancer|March 22, 2025
Treatment Adherence to Adjuvant Chemotherapy According to the New Standard 3-month CAPOX Regimen in High-risk Stage II and Stage III Colon Cancer: A Population-based Evaluation in The NetherlandsKim van den Berg, Felice N van Erning, Jacobus Wa Burger, et al.
Journal of Geriatric Oncology|February 24, 2015
Deciding on adjuvant chemotherapy for elderly patients with stage III colon cancer: a qualitative insight into the perspectives of surgeons and medical oncologistsFelice N van Erning, Maryska L G Janssen-Heijnen, Geert-Jan Creemers, et al.
The Oncologist|August 12, 2025
Emerging treatment modalities for gastric cancer with peritoneal metastases: A systematic reviewMarion Wilhelmina Tops-Welten, Laskarina Jaklien Konstantina Galanos, Geert-Jan Creemers, et al.
Journal of Clinical Gastroenterology|March 31, 2012
The effect of socioeconomic status on staging and treatment decisions in esophageal cancerPauline Bus, Mieke J Aarts, Valery E P P Lemmens, et al.
Annals of Surgical Oncology|February 5, 2016
Local Recurrence in the Lateral Lymph Node Compartment: Improved Outcomes with Induction Chemotherapy Combined with Multimodality TreatmentMiranda Kusters, Sietske J Bosman, Desley M G I Van Zoggel, et al.
Cancer Medicine|September 28, 2016
The use of adjuvant chemotherapy for pancreatic cancer varies widely between hospitals: a nationwide population-based analysisMaikel J Bakens, Lydia G van der Geest, Magreet van Putten, et al.
American Journal of Clinical Oncology|February 9, 2012
Addition of biological therapies to palliative chemotherapy prolongs survival in patients with peritoneal carcinomatosis of colorectal originYvonne L B Klaver, Bart J M Leenders, Geert-Jan Creemers, et al.
Pageof 10